ANDREA CORTES DOBSON: Open Payments
NPI 1366952285 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 56 payments from 13 companies in 2025. Trend: 2023 $958 · 2024 $1,375 · 2025 $1,335
Food & beverage: $1,140Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $326 |
| Galderma Laboratories, L.P. | 10 | $178 |
| Janssen Biotech, Inc. | 6 | $168 |
| LEO Pharma Inc. | 3 | $147 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $141 |
| UCB, Inc. | 7 | $139 |
| Organon LLC | 5 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| GENZYME CORPORATION | 1 | $34 |
Products named: SKYRIZI, TREMFYA, Bimzelx, NEMLUVIO, ANZUPGO, RINVOQ, Sotyktu, ADBRY.
Industry payments across ID — which companies pay providers there.
